Advertisement
BD Biosciences
BD Biosciences

FDA Approves NGS Tests

The agency has cleared marketing of four next-generation sequencing devices from Illumina.

By | November 21, 2013

WIKIMEDIA, WEBRIDGEThe US Food and Drug Administration (FDA) yesterday (November 20) granted market approval for four diagnostic devices from Illumina based on next-generation sequencing (NGS). According to the agency, the San Diego-based firm is now free to market its MiSeqDx Cystic Fibrosis 139-Variant Assay and MiSeqDx Cystic Fibrosis Clinical Sequencing Assay, both of which can detect aberrations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, for clinical use.

“NGS is changing the way we look at genomics,” Alberto Gutierrez, director of the Office of In Vitro Diagnostics and Radiological Health in FDA’s Center for Devices and Radiological Health, said in a statement. “Before NGS, sequencing genes associated with a particular disease was a long and costly process. Today, we have the capability to read and interpret large segments of DNA very quickly in a single test, and this information-rich technology is becoming more accessible for use by physicians in the care of their patients.”

In a New England Journal of Medicine commentary, FDA Commissioner Margaret Hamburg and National Institutes of Health Director Francis Collins noted the significance of these federal approvals for NGS. “The marketing authorization of a sequencing platform for clinical use will probably expand the incorporation of genetic information into health care,” they wrote.

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo
Advertisement
EMD Millipore
EMD Millipore

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  3. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

  4. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

Advertisement
INTEGRA
INTEGRA
Advertisement
Life Technologies